Cargando...
“Albumin Hitchhiking” with an Evans Blue Analog for Cancer Theranostics
Although (177)Lu-DOTA-TATE was recently approved in Europe for the treatment of certain neuroendocrine tumors, continued development and optimization has been ongoing to further improve the therapeutic efficacy of somatostatin receptor 2 targeted peptide receptor radionuclide therapy, as well as red...
Gardado en:
| Publicado en: | Theranostics |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Ivyspring International Publisher
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5771095/ https://ncbi.nlm.nih.gov/pubmed/29344308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.24183 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|